Literature DB >> 15291273

Benefits of cochlear implantation in early-deafened adults: the Toronto experience.

Gerard H Chee1, Jennifer E Goldring, David B Shipp, Amy H C Ng, Joseph M Chen, Julian M Nedzelski.   

Abstract

OBJECTIVE: To present the results of a survey administered to a group of early-deafened cochlear implants adults and to report the level of perceived benefit.
DESIGN: Prospective.
SETTING: Large tertiary referral centre.
METHOD: A 47-item questionnaire designed to evaluate cochlear implant use and benefit was sent to 42 early-deafened adult cochlear implant users. The questionnaire can be divided into seven subcategories: time of use, associated symptoms, communication, employment status and function, socialization, perceived benefit, and the impact on quality of life. Responses from 30 patients were received.
RESULTS: The majority of our patients use their cochlear implant all of their waking hours. The majority of patients continue to depend on lip-reading and hearing as their main mode of communication, although they reported improved lip-reading skills with their cochlear implant. Twenty-three patients (76.7%) were employed. Eleven patients had a change in employment subsequent to cochlear implantation, nine (81.8%) of whom attributed this to their cochlear implant. Our patients als reported greater independence, a greater sense of safety in their environment, and an improved social life. Twenty-nine patients (96.7%) said that they were satisfied with their implant, 28 (93.3%) said that they would go through the same process again, and 27 (90%) said that they would recommend it to a friend in a similar situation. Twenty-nine patients (96.7%) stated that the cochlear implant has had a positive effect on their quality of life. Family and peer support, prior auditory-verbal therapy, and a positive attitude were the most commonly cited factors in successful cochlear implant use.
CONCLUSIONS: Early-deafened adult cochlear implant users perceive significant benefit from cochlear implantation. Importantly, family and peer support, prior auditory-verbal therapy, and a positive attitude are considered important factors in maximizing this benefit.

Entities:  

Mesh:

Year:  2004        PMID: 15291273     DOI: 10.2310/7070.2004.01074

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  6 in total

1.  Results of Postoperative, CT-based, Electrode Deactivation on Hearing in Prelingually Deafened Adult Cochlear Implant Recipients.

Authors:  Robert F Labadie; Jack H Noble; Andrea J Hedley-Williams; Linsey W Sunderhaus; Benoit M Dawant; René H Gifford
Journal:  Otol Neurotol       Date:  2016-02       Impact factor: 2.311

2.  Towards self-determination in quality of life research: a dialogic approach.

Authors:  Leah McClimans
Journal:  Med Health Care Philos       Date:  2009-03-10

3.  Long term results in late implanted adolescent and adult CI recipients.

Authors:  Ersilia Bosco; Maria Nicastri; Deborah Ballantyne; Marika Viccaro; Giovanni Ruoppolo; Alessandra Ionescu Maddalena; Patrizia Mancini
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-23       Impact factor: 2.503

4.  ERP evidence for the recognition of emotional prosody through simulated cochlear implant strategies.

Authors:  Deepashri Agrawal; Lydia Timm; Filipa Campos Viola; Stefan Debener; Andreas Büchner; Reinhard Dengler; Matthias Wittfoth
Journal:  BMC Neurosci       Date:  2012-09-20       Impact factor: 3.288

Review 5.  Systematic review of the literature on the clinical effectiveness of the cochlear implant procedure in adult patients.

Authors:  S Berrettini; A Baggiani; L Bruschini; E Cassandro; D Cuda; R Filipo; I Palla; N Quaranta; F Forli
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-10       Impact factor: 2.124

6.  Cochlear implant in prelingually deafened oralist adults: speech perception outcomes, subjective benefits and quality of life improvement.

Authors:  F Forli; G Turchetti; G Giuntini; S Bellelli; S Fortunato; L Bruschini; M R Barillari; S Berrettini
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.